Skip to content

Cart

Your cart is empty

Acetyl glycyl β-alanyl

Acetyl Glycyl Beta-Alanine is a synthetic tripeptide specifically designed to regulate melanogenesis — the biological process of melanin production — through a targeted mechanism that operates upstream of pigmentation at the gene expression level. Unlike most conventional depigmenting actives that work by blocking tyrosinase activity, this peptide intervenes earlier in the cascade, modulating the signals that determine how much melanin melanocytes are instructed to produce in the first place.

Acetyl Glycyl Beta-Alanine : precision regulation of melanin production

Melanin synthesis is triggered by a signaling cascade initiated by alpha-MSH (alpha-melanocyte-stimulating hormone), which binds to MC1R receptors on melanocytes and activates a series of intracellular pathways leading to the production of both tyrosinase and the transcription factor MITF — the master regulator of melanocyte activity. In conditions of chronic UV exposure, or post-inflammatory response, this cascade becomes overactivated, producing the excess and uneven melanin deposits.

Acetyl Glycyl Beta-Alanine acts as a competitive antagonist at the MC1R receptor, mimicking the structure of beta-endorphin — a natural inhibitor of alpha-MSH — and blocking its binding to the receptor. By interrupting the upstream signal before it reaches the melanocyte, the peptide reduces MITF expression and downstream tyrosinase activity, resulting in a measurable decrease in melanin production without cytotoxic effects on melanocytes themselves. This preserves the integrity of the melanocyte while progressively correcting existing pigmentation.

Skin benefits

Acetyl Glycyl Beta-Alanine is a precision pigment modulating peptide acting at the earliest stage of the melanin production cascade for progressive, targeted correction of dark spots and uneven skin tone.

  • Reduces melanin overproduction by blocking the upstream hormonal signal that triggers melanocyte activation
  • Corrects established dark spots, post-inflammatory hyperpigmentation, and uneven skin tone with sustained use
  • Well-tolerated at the cellular level — does not cause melanocyte cytotoxicity, supporting safe long-term use
  • Complements the action of other depigmenting actives by targeting a distinct step in the melanogenesis cascade, broadening the overall corrective effect